Format

Send to

Choose Destination
Front Mol Neurosci. 2014 Feb 4;7:6. doi: 10.3389/fnmol.2014.00006. eCollection 2014.

Developing a PPI inhibitor-based therapy for STXBP1 haploinsufficiency-associated epileptic disorders.

Author information

1
Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge Cambridge, UK ; Department of Physiology, Development and Neuroscience, University of Cambridge Cambridge, UK.

KEYWORDS:

Munc18; Ohtahara syndrome; PPI inhibitor; STXBP1; West syndrome; epileptic encephalopathy; infantile spasms; syntaxin1a

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center